Ignite Creation Date:
2024-05-06 @ 3:06 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04529044
Status:
UNKNOWN
Last Update Posted:
2022-07-11
First Post:
2020-08-24
Brief Title:
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
Sponsor:
OHSU Knight Cancer Institute
Organization:
OHSU Knight Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-20
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-24
First Submit QC Date:
August 24 2020
Study First Post Date:
2020-08-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-07
Last Update Post Date:
2022-07-11
Last Update Post Date Type:
ACTUAL